Table.
Basic Characteristics of RAO Patients Grouped by Antithrombotic Treatment Received Any Time the First 3 to 90 Days After RAO
| Treatment | ||||||
|---|---|---|---|---|---|---|
| Characteristic | Aspirin (n = 3144) | Clopidogrel (n = 1443) | Anticoagulant (n = 723) | Other Antiplatelet (n = 34) | Untreated (n = 1820) | Total (n = 6628) |
| Age (yr), mean (SD) | 71.1 (11.7) | 70.6 (11) | 73 (11.4) | 69.2 (11.2) | 66.3 (14.2) | 69.8 (12.5) |
| Female sex, n (%) | 1476 (47.0) | 622 (43.1) | 274 (37.9) | 10 (29.4) | 853 (47.5) | 3006 (45.5) |
| Diabetes, n (%) | 547 (17.4) | 277 (19.2) | 157 (21.7) | 12 (35.3) | 218 (12.0) | 1086 (16.4) |
| Hypertension, n (%) | 951 (30.2) | 516 (35.8) | 360 (49.8) | 16 (47.1) | 280 (15.4) | 1859 (28.0) |
| Heart failure, n (%) | 279 (8.9) | 107 (7.4) | 191 (26.4) | 6 (17.6) | 68 (3.7) | 562 (8.5) |
| Chronic kidney disease, n (%) | 201 (6.4) | 92 (6.4) | 89 (12.3) | 0 (0.0) | 76 (4.2) | 401 (6.1) |
| Cancer, n (%) | 472 (15.0) | 254 (17.6) | 140 (19.4) | 6 (17.6) | 217 (11.9) | 984 (14.8) |
| Atrial fibrillation, n (%) | 233 (7.4) | 65 (4.5) | 471 (65.1) | 4 (11.8) | 63 (3.5) | 699 (10.5) |
| Ischemic heart disease, n (%) | 835 (26.6) | 403 (27.9) | 331 (45.8) | 29 (85.3) | 185 (10.2) | 1547 (23.3) |
| Any antithrombotic treatment 2 years prior to the RAO, n (%) | 2053 (65.3) | 819 (56.8) | 631 (87.3) | 29 (85.3) | 185 (10.2) | 3288 (49.6) |
The treatment groups are not exclusive. The untreated group includes patients with RAO who did not receive any antithrombotic treatment at any time during the first 3 to 90 days after RAO. The total group includes all patients having RAO after inclusion.